EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The liver-brain axis, from its function to preventive therapeutic strategies in diseases

Yaoyao Chen, Shangcheng Xu, Tao Sun

Frontiers in Endocrinology · 26.06.2026 · 17

DOI: 10.3389/fendo.2026.1858091 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, online erschienen am 26.06.2026. Verfasst von Yaoyao Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Precision Medicine, School of Medicine and School of Biomedical Sciences, Huaqiao University, Xiamen, China. Hauptthemen laut MEDLINE: Liver, Brain, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The liver-brain axis (LBA) represents a bidirectional communication network between the liver and the central nervous system (CNS), governed by integrated neural, humoral, and immune signaling pathways. Emerging evidence indicates that the liver functions not merely as a passive metabolic organ subordinate to central commands, but rather as a dynamic hub that actively senses and modulates peripheral neuroimmune responses. We here first delineate the fundamental communication mechanisms and the transport kinetics of signaling molecules governing LBA interactions. We then examine the profound species-specific disparities between humans and mice—particularly regarding signaling mediators, blood-brain barrier (BBB) architecture, and the hepatic immune microenvironment. From a pathophysiological perspective, we establish that LBA dysfunction serves as a core driver of obesity, diabetes, and their multisystemic sequelae, including cardiovascular diseases and psychiatric disorders such as anxiety and depression. Finally, we highlight recent therapeutic advances targeting the LBA for the management of metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic dysfunction-associated steatohepatitis (MASH), atherosclerosis, and associated psychiatric conditions, thereby underscoring the immense clinical potential of LBA-targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverBrainLiver DiseasesHumansAnimalsBlood-Brain BarrierObesitySignal Transduction

Stichwörter der Autor:innen

central nervous systemdiabetesliver-brain axisobesitypsychiatric disorders

Autor:innen und Institutionen

  • Center for Precision Medicine, School of Medicine and School of Biomedical Sciences, Huaqiao University, Xiamen, China.
  • GeneYoung Biopharmaceuticals, Shenzhen, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Xu, S., & Sun, T. (2026). The liver-brain axis, from its function to preventive therapeutic strategies in diseases. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1858091

Vancouver

Chen Y, Xu S, Sun T. The liver-brain axis, from its function to preventive therapeutic strategies in diseases. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1858091

BibTeX
@article{Chen2026,
  author = {Chen, Yaoyao and Xu, Shangcheng and Sun, Tao},
  title = {The liver-brain axis, from its function to preventive therapeutic strategies in diseases},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fendo.2026.1858091}
}
Kostenlos starten →